HSBC Holdings plc set a €105.00 ($123.53) target price on Bayer AG (FRA:BAYN) in a report issued on Wednesday. The brokerage currently has a neutral rating on the healthcare company’s stock.

A number of other equities analysts have also recently issued reports on the company. UBS AG set a €125.00 ($147.06) target price on Bayer AG and gave the stock a buy rating in a report on Friday, May 12th. J P Morgan Chase & Co set a €125.00 ($147.06) target price on Bayer AG and gave the stock a buy rating in a report on Monday, July 3rd. Baader Bank set a €120.00 ($141.18) target price on Bayer AG and gave the stock a neutral rating in a report on Monday, July 3rd. BNP Paribas set a €103.00 ($121.18) target price on Bayer AG and gave the stock a neutral rating in a report on Monday, July 3rd. Finally, Deutsche Bank AG set a €124.00 ($145.88) target price on Bayer AG and gave the stock a buy rating in a report on Monday, July 24th. Nine research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Bayer AG has a consensus rating of Buy and an average target price of €119.73 ($140.86).

Shares of Bayer AG (BAYN) opened at 108.902 on Wednesday. Bayer AG has a 1-year low of €85.72 and a 1-year high of €123.83. The firm has a market cap of €94.97 billion and a PE ratio of 18.838. The company has a 50-day moving average of €108.88 and a 200-day moving average of €110.84.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/08/27/hsbc-holdings-plc-analysts-give-bayer-ag-bayn-a-105-00-price-target.html.

Bayer AG Company Profile

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.